Home › Research › Vascular contributions
Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
Luke E. Stoeckel, Elena M. Fazio, Kristina K. Hardy, Nicole Kidwiler, Kristina A. McLinden, Benfeard Williams. Alzheimer s & Dementia Translational Research & Clinical Interventions, 2025-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Abstract On March 12–14, 2024, the National Institute on Aging (NIA) together with the National Institute of Neurological Disorders and Stroke (NINDS) led a workshop exploring clinically meaningful changes in the context of Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) clinical trials ( https://www.nia.nih.gov/research/dbsr/workshops/clinically‐meaningful‐outcomes‐ad‐adrd‐trials ). The goals were to identify research gaps, opportunities, and tools to advance patient‐centered, equitable assessment of clinically meaningful change focused on biomarker status, cognition, and everyday function. The workshop fostered robust, multidisciplinary discussion between lived experience experts, advocates, researchers, clinicians, funders, payers, and regulators. The workshop addressed the criteria used to assess whether an intervention has had a clinically meaningful impact, including consideration of both benefit and harm. Here, we report on (1) criteria to consider for development, testing, and selection of clinically meaningful outcomes in AD/ADRD clinical trials; (2) methods to validate and customize clinically meaningful outcomes that are fit‐for‐purpose; and (3) practices that will ensure that clinically meaningful outcomes are applicable to diverse populations. Highlights Patient‐Centered Outcomes : Inclusive AD/ADRD clinical trials incorporate assessments that reflect what matters most to those impacted by these diseases, including patient‐ and caregiver‐reported outcome measures. Culturally Relevant Assessments : There is a need for culturally sensitive and equitable assessments to better serve diverse populations in AD/ADRD research. Framework for Clinically Meaningful Change : We present a framework for defining and evaluating clinically meaningful outcomes in AD/ADRD trials, tailored to diverse stages of disease progression. Interdisciplinary Approach : We draw on insights from a multidisciplinary workshop, fostering collaboration among researchers, clinicians, and lived experience experts to advance the field.
What this study adds
Evidence grade: Low
This report describes a workshop on how to define and measure clinically meaningful change in Alzheimer's and related dementia trials, focused on biomarkers, cognition and everyday function. It offers guidance for trial design and outcome selection rather than findings about treating, curing or preventing the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Stoeckel, L. E., Fazio, E. M., Hardy, K. K., Kidwiler, N., McLinden, K. A., & Williams, B. (2025). Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials. Alzheimer s & Dementia Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70058
Vancouver
Stoeckel LE, Fazio EM, Hardy KK, Kidwiler N, McLinden KA, Williams B. Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2025. doi:10.1002/trc2.70058. PMID: 39975465.
BibTeX
@article{stoeckel2025-39975465,
author = {Stoeckel, Luke E. and Fazio, Elena M. and Hardy, Kristina K. and Kidwiler, Nicole and McLinden, Kristina A. and Williams, Benfeard},
title = {{Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials}},
journal = {Alzheimer s \& Dementia Translational Research \& Clinical Interventions},
year = {2025},
doi = {10.1002/trc2.70058},
pmid = {39975465},
url = {https://doi.org/10.1002/trc2.70058}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Here, we report on (1) criteria to consider for development, testing, and selection of clinically meaningful outcomes in AD/ADRD clinical trials; (2) methods to validate and customize clinically meaningful outcomes that are fit‐for‐purpose; and (3) practices that will ensure that clinically meaningful outcomes are applicable to diverse populations.
- Highlights Patient‐Centered Outcomes : Inclusive AD/ADRD clinical trials incorporate assessments that reflect what matters most to those impacted by these diseases, including patient‐ and caregiver‐reported outcome measures.
- Culturally Relevant Assessments : There is a need for culturally sensitive and equitable assessments to better serve diverse populations in AD/ADRD research.
- Framework for Clinically Meaningful Change : We present a framework for defining and evaluating clinically meaningful outcomes in AD/ADRD trials, tailored to diverse stages of disease progression.
- Interdisciplinary Approach : We draw on insights from a multidisciplinary workshop, fostering collaboration among researchers, clinicians, and lived experience experts to advance the field.
Why it matters
This report describes a workshop on how to define and measure clinically meaningful change in Alzheimer's and related dementia trials, focused on biomarkers, cognition and everyday function. It offers guidance for trial design and outcome selection rather than findings about treating, curing or preventing the disease.
Study details
- Evidence strengthLow
How this study scored 39/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Translational Research & Clinical Interventions) |
| Journal's citation record | 1 / 4 | Alzheimer s & Dementia Translational Research & Clinical Interventions: journal h-index 84 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 13 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 8.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 13 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Benfeard Williams: h-index 9 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | National Institute on Aging: institution h-index 907 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39975465) |
| Free to read | 2 / 2 | Free to read |
| Total | 39 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/trc2.70058
- PubMed: 39975465
- Original source →
- Free full text: Alzheimer s & Dementia Translational Research & Clinical Interventions →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Vascular contributions from nearby years
Also in Vascular contributions
53 studies in the library are filed under Vascular contributions with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Vascular contributions hub.